Table 1. Prevalence of COPD in COVID-19 patients from 26 database cohorts in 7 countries.
| Cohort |
US
CU-AMC |
US
CUIMC |
US
HealthVerity |
US
IQVIA OpenClaims |
US
Optum EHR |
US
STARR- OMOP |
US
VA-OMOP |
KR
HIRA |
UK
CPRD |
NL
IPCI |
ES
SIDIAP |
FR
LPD France |
IT
LPD Italy |
| Diagnosed COVID-19 | 7270 | 8519 | 114173 | 466191 | 129512 | 3328 | 55557 | - | 3372 | 3047 | 122141 | 17180 | 4488 |
| COPD (n) | 692 | 770 | 6500 | 68262 | 11056 | 218 | 12610 | - | 261 | 200 | 15803 | 648 | 340 |
| Prevalence (%), 95%CI | 9.5
8.9-10.2 |
9.0
8.4-9.7 |
5.7
5.6-5.8 |
14.6
14.5-14.7 |
8.5
8.4-8.7 |
6.6
5.8-7.4 |
22.7
22.4-23.0 |
- | 7.7
6.9-8.7 |
6.6
5.7-7.5 |
12.9
12.8-13.1 |
3.8
3.5-4.1 |
7.6
6.8-8.4 |
| Hospitalized COVID-19 | 1434 | 2600 | 7581 | 133091 | 22024 | - | 10471 | 7599 | - | - | 18202 | - | - |
| COPD (n) | 299 | 447 | 1649 | 30917 | 4504 | - | 4611 | 145 | - | - | 4843 | - | - |
| Prevalence (%), 95%CI | 20.9
18.8-23.0 |
17.2
15.8-18.7 |
21.8
20.8-22.7 |
23.2
23.0-23.5 |
20.5
19.9-21.0 |
- | 44.0
43.1-45.0 |
1.9
1.6-2.2 |
- | - | 26.6
26.0-27.3 |
- | - |
Grey =US database. Pink=South Korean database. Yellow=European database. US=United States. KR=South Korea. UK=United Kingdom. NL=Netherlands. ES=Spain. (n) = number. NA= not applicable for that cohort.